Junshi Bio (01877) Elevates Strategic Focus with New ESG Mandate and Drafts Director & Executive Pay Policies

Bulletin Express

Mar 13

Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio, 01877) has restructured its board-level Strategic Committee into a “Strategic and ESG Committee”, effective 13 March 2026, to integrate environmental, social and governance (ESG) oversight into long-term corporate strategy and investment decisions. Committee membership, tenure and other organisational parameters remain unchanged; only the mandate is broadened to include ESG responsibilities.

The board also approved the formulation of Remuneration Policies for Directors and Senior Management aimed at establishing a more systematic incentive and restraint mechanism. Implementation of the remuneration framework is subject to shareholder approval via ordinary resolution at the forthcoming general meeting.

Revised terms of reference for the Strategic and ESG Committee and the new remuneration policies will be published on the company’s website, as well as on the Hong Kong and Shanghai stock exchange platforms.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1177993856"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1177993856\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1177993856?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 20:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177993856","market":"hk","top_or_hot":-1,"title":"Junshi Bio (01877) Elevates Strategic Focus with New ESG Mandate and Drafts Director & Executive Pay Policies","media":"Bulletin Express","content":"<p>Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio, 01877) has restructured its board-level Strategic Committee into a “Strategic and ESG Committee”, effective 13 March 2026, to integrate environmental, social and governance (ESG) oversight into long-term corporate strategy and investment decisions. Committee membership, tenure and other organisational parameters remain unchanged; only the mandate is broadened to include ESG responsibilities.</p>\n<p>The board also approved the formulation of Remuneration Policies for Directors and Senior Management aimed at establishing a more systematic incentive and restraint mechanism. Implementation of the remuneration framework is subject to shareholder approval via ordinary resolution at the forthcoming general meeting.</p>\n<p>Revised terms of reference for the Strategic and ESG Committee and the new remuneration policies will be published on the company’s website, as well as on the Hong Kong and Shanghai stock exchange platforms.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Junshi Bio (01877) Elevates Strategic Focus with New ESG Mandate and Drafts Director & Executive Pay Policies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJunshi Bio (01877) Elevates Strategic Focus with New ESG Mandate and Drafts Director & Executive Pay Policies\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-13 20:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio, 01877) has restructured its board-level Strategic Committee into a “Strategic and ESG Committee”, effective 13 March 2026, to integrate environmental, social and governance (ESG) oversight into long-term corporate strategy and investment decisions. Committee membership, tenure and other organisational parameters remain unchanged; only the mandate is broadened to include ESG responsibilities.</p>\n<p>The board also approved the formulation of Remuneration Policies for Directors and Senior Management aimed at establishing a more systematic incentive and restraint mechanism. Implementation of the remuneration framework is subject to shareholder approval via ordinary resolution at the forthcoming general meeting.</p>\n<p>Revised terms of reference for the Strategic and ESG Committee and the new remuneration policies will be published on the company’s website, as well as on the Hong Kong and Shanghai stock exchange platforms.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01877","symbol_name":"君实生物","start_time":0,"source_url":"","article_id":"1177993856","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177993856","pubTimestamp":1773403254,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio, 01877) has restructured its board-level Strategic Committee into a “Strategic and ESG Committee”, effective 13 March 2026, to integrate...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01877":"君实生物"},"translate_title":"君实生物(01877)通过新的ESG授权提升战略重点并起草董事和高管薪酬政策","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01877":1},"content_text":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio, 01877) has restructured its board-level Strategic Committee into a “Strategic and ESG Committee”, effective 13 March 2026, to integrate environmental, social and governance (ESG) oversight into long-term corporate strategy and investment decisions. Committee membership, tenure and other organisational parameters remain unchanged; only the mandate is broadened to include ESG responsibilities.\nThe board also approved the formulation of Remuneration Policies for Directors and Senior Management aimed at establishing a more systematic incentive and restraint mechanism. Implementation of the remuneration framework is subject to shareholder approval via ordinary resolution at the forthcoming general meeting.\nRevised terms of reference for the Strategic and ESG Committee and the new remuneration policies will be published on the company’s website, as well as on the Hong Kong and Shanghai stock exchange platforms.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}